Treatments

Weight Loss

We offer concierge weight loss services to address a national epidemic of obesity. Until recently it has been a challenge to provide a pharmaceutical option for obesity. Exciting clinical studies published in the New England Journal of Medicine (March 18, 2021) look at semaglutide for weight loss. This study was a double-blinded placebo study (the best study possible) that looked at weight loss. The average patient lost 15.3 kgs. This is over a 68-week period. We are excited to provide this as a therapeutic option so that we will reduce your risk of diabetes, heart disease, knee problems, back problems, hyperlipidemia, and sleep apnea. Weight loss is the cornerstone of health. We are here to journey with you in your weight loss. We are here to provide a supportive and positive environment for you to achieve your long-term success. We measure weight loss in years, rather than months. We have attached some data from the study in the Research section of our website. Again, our research is based on cutting-edge science with transparent billing. We have a compounding pharmacy to provide low-cost semaglutide for your journey.